You need to be logged in to view this video
Join moderator Jeffrey Hirsch with panelists David Mazza and Kevin Kelly for a drill down into the newest levereged and inverse ETFs from Direxion and the latest, hottest trends in biotech ETF investing from Kelly ETFs.
![](https://cdn.moneyshow.com/mscache/spk-images/845160SPK_80x80.jpg?v=2)
Jeffrey Hirsch
The Stock Trader's Almanac & Almanac Investor,
Editor-in-Chief
![](https://cdn.moneyshow.com/mscache/spk-images/1122434SPK_80x80.jpg?v=2)
Kevin Kelly
Kelly ETFs,
CEO
![](https://cdn.moneyshow.com/mscache/spk-images/1116659SPK_80x80.jpg?v=2)
David Mazza
Direxion,
Managing Director, Head of Product
Trending Now
Filter By Category
Filter By Keywords
Loading...